Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FDA Approves Nexavar for Thyroid Cancer | Contract Pharma

What are you searching for?

Sign in

FDA Approves Nexavar for Thyroid Cancer

Bayer/Onyx drug gains expanded indication

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

The FDA has expanded the approved use of the cancer drug Nexavar to include late-stage differentiated thyroid cancer, the most common type of thyroid cancer.

Nexavar is made by Bayer AG and Onyx Pharmaceuticals and is also approved to treat advanced kidney cancer and liver cancer. Onyx was acquired by Amgen earlier this year.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters